Cronos (CRON) Other Non Operating Income (2019 - 2026)
Cronos' (CRON) quarterly Other Non Operating Income came in at $10000.0 in Q1 2026, down 99.37% year-on-year from $1.6 million in Q1 2025, and up 100.1% quarter-over-quarter from -$10.4 million in Q4 2025.
Cronos (CRON) Other Non Operating Income (2019 - 2026) Analysis & Trends
Cronos' Other Non Operating Income history runs 8 years deep, the most recent figure standing at $10000.0 for Q1 2026.
- On a quarterly basis, Other Non Operating Income fell 99.37% year-over-year to $10000.0 in Q1 2026; TTM through Mar 2026 was -$30.2 million, a 170.38% decrease from a year earlier, with the FY2025 full-year figure at -$28.6 million, down 9397.67% from the prior year.
- Other Non Operating Income grew to $10000.0 in Q1 2026 per CRON's latest filing, from -$10.4 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at $19.8 million in Q3 2025 and bottomed at -$39.5 million in Q2 2025.
- The 5-year median for Other Non Operating Income is -$581000.0 (2022), against an average of -$1.9 million.
- Biggest YoY gain for Other Non Operating Income was 6380.95% in 2025; the steepest drop was 16042.74% in 2025.
- Year by year, Other Non Operating Income stood at $16.4 million in 2022, then tumbled by 169.06% to -$11.3 million in 2023, then slipped by 11.9% to -$12.7 million in 2024, then advanced by 17.78% to -$10.4 million in 2025, then jumped by 100.1% to $10000.0 in 2026.
- Per Business Quant, the three latest CRON Other Non Operating Income figures stand at $10000.0 (Q1 2026), -$10.4 million (Q4 2025), and $19.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Cronos | 1.04 Bn | 267.78 Mn | 19.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10,000.00 |
| Dec 31, 2025 | -10.42 Mn |
| Sep 30, 2025 | 19.79 Mn |
| Jun 30, 2025 | -39.54 Mn |
| Mar 31, 2025 | 1.58 Mn |
| Dec 31, 2024 | -12.67 Mn |
| Sep 30, 2024 | -315,000.00 |
| Jun 30, 2024 | 248,000.00 |
| Mar 31, 2024 | 13.26 Mn |
| Dec 31, 2023 | -11.32 Mn |
| Sep 30, 2023 | 974,000.00 |
| Jun 30, 2023 | -3.17 Mn |
| Mar 31, 2023 | -1.64 Mn |
| Dec 31, 2022 | 16.40 Mn |
| Sep 30, 2022 | -581,000.00 |
| Jun 30, 2022 | -2.85 Mn |
| Mar 31, 2022 | -1.87 Mn |
| Dec 31, 2021 | -131.29 Mn |
| Sep 30, 2021 | 130.26 Mn |
| Mar 31, 2021 | -16,000.00 |